Abstract
Small bioactive molecules are pre-requisite for any discovery discipline. Being aware of the fact that bioactivity is not randomly dispersed in the vast chemical space, chemists have been developing hypothesis that can provide access to these islands of bioactivities. Natural products have always been a source of inspiration and their structural motifs provide biologically relevant starting points for library synthesis. In addition to that, Diversity Oriented Synthesis (DOS) and Biology Oriented Synthesis (BIOS) have emerged other tools to guide synthesis design and help enrich compound collections in biological activities. Coherent developments in chem- and bioinformatic tools and in organic synthesis methods targeting efficient synthesis of compound collections are required to identify interesting molecules that can be employed as probes in chemical biology research and as drug candidates in medicinal chemistry investigations.
Keywords: Natural products, diversity oriented synthesis, biology oriented synthesis, compound libraries, small molecules, drug discovery, bioactivity, protein inhibitor, cyclopeptides, chemical space
Current Drug Targets
Title: Exploring and Exploiting Biologically Relevant Chemical Space
Volume: 12 Issue: 11
Author(s): Luc Eberhardt, Kamal Kumar and Herbert Waldmann
Affiliation:
- Max-Planck-Institute of Molecular Physiology, Department of Chemical Biology, Otto-Hahn-StraBe 11, 44227 Dortmund, Germany.,Germany
Keywords: Natural products, diversity oriented synthesis, biology oriented synthesis, compound libraries, small molecules, drug discovery, bioactivity, protein inhibitor, cyclopeptides, chemical space
Abstract: Small bioactive molecules are pre-requisite for any discovery discipline. Being aware of the fact that bioactivity is not randomly dispersed in the vast chemical space, chemists have been developing hypothesis that can provide access to these islands of bioactivities. Natural products have always been a source of inspiration and their structural motifs provide biologically relevant starting points for library synthesis. In addition to that, Diversity Oriented Synthesis (DOS) and Biology Oriented Synthesis (BIOS) have emerged other tools to guide synthesis design and help enrich compound collections in biological activities. Coherent developments in chem- and bioinformatic tools and in organic synthesis methods targeting efficient synthesis of compound collections are required to identify interesting molecules that can be employed as probes in chemical biology research and as drug candidates in medicinal chemistry investigations.
Export Options
About this article
Cite this article as:
Eberhardt Luc, Kumar Kamal and Waldmann Herbert, Exploring and Exploiting Biologically Relevant Chemical Space, Current Drug Targets 2011; 12(11) . https://dx.doi.org/10.2174/138945011798109482
DOI https://dx.doi.org/10.2174/138945011798109482 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases
Current Pharmaceutical Design Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy Intriguing Classes of Acridine Derivatives as DNA-binding Antitumour Agents: From Pyrimido[5,6,1-de]acridines to Bis(acridine-4-carboxamides)
Medicinal Chemistry Reviews - Online (Discontinued) Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design Development of Novel Protein Scaffolds as Alternatives to Whole Antibodies for Imaging and Therapy: Status on Discovery Research and Clinical Validation
Current Pharmaceutical Biotechnology Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology
Current Cancer Drug Targets Mechanisms Involved in Apoptosis Events Contributing to Sepsis-Induced Myocardial Dysfunction
Current Drug Therapy Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
Current Pharmaceutical Design Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity
Medicinal Chemistry Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Current Genomics Hematological Targets of Radiation Damage
Current Drug Targets Neuroprotective Role of Natural Polyphenols
Current Topics in Medicinal Chemistry Restoration of Chemoresistance Mechanism by Novel Drug Therapies in Breast Cancer Cell Lines
Current Drug Therapy Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery Management of Early Stage Chronic Myeloid Leukemia: State-of-the-art Approach and Future Perspectives
Current Cancer Drug Targets Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Current Drug Metabolism Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy Bortezomib and Arsenious Acid Synergistically Inhibit HL-60 Cells Viability in vitro and in vivo
Current Signal Transduction Therapy